In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy

NeuroImage

Volumn 101, Issue , 2014, Pages 185-192

  Crescenzi, Rachelle ^a,b   DeBrosse, Catherine ^a,b   Nanga, Ravi Prakash Reddy ^b   Reddy, Sanjana ^b   Haris, Mohammed ^b   Hariharan, Hari ^b   Iba, Michiyo ^b   Lee, Virginia M Y ^b   Detre, John A ^b   Borthakur, Arijitt ^b   Reddy, Ravinder ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemical exchange saturation transfer; Dentate gyrus; Glutamate; Neurogenesis; Synapse loss; Tauopathy

Indexed keywords

GLUTAMIC ACID; TAU PROTEIN;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DENTATE GYRUS; GLUTAMATE CHEMICAL EXCHANGE SATURATION TRANSFER IMAGING; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SYNAPTIC TRANSMISSION; TAUOPATHY; THALAMUS; ANIMAL; DISEASE MODEL; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SYNAPSE; TRANSGENIC MOUSE;

ANIMALS; DENTATE GYRUS; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; HIPPOCAMPUS; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; NEUROGENESIS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; SYNAPSES; TAUOPATHIES; THALAMUS;

EID: 84904858789     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2014.06.067     Document Type: Article

References (30)

1. Albers D.S., Augood S.J., Park L.C.H., Browne S.E., Martin D.M., Adamson J., Hutton M., Standaert D.G., Vonsattel J.P.G., Gibson G.E., Beal M.F. Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment. J. Neurochem. 2000, 74(2):878-881.
2. Alonso A.D., Zaidi T., Novak M., Grundke-Iqbal I., Iqbal K. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(12):6923-6928.
3. Ballatore C., Lee V.M.Y., Trojanowski J.Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 2007, 8(9):663-672.
4. Brunden K.R., Zhang B., Carroll J., Yao Y.M., Potuzak J.S., Hogan A.M.L., Iba M., James M.J., Xie S.X., Ballatore C., Smith A.B., Lee V.M.Y., Trojanowski J.Q. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J. Neurosci. 2010, 30(41):13861-13866.
5. Cai K.J., Haris M., Singh A., Kogan F., Greenberg J.H., Hariharan H., Detre J.A., Reddy R. Magnetic resonance imaging of glutamate. Nat. Med. 2012, 18(2):302-306.
6. Chohan M.O., Li B., Blanchard J., Tung Y.C., Heaney A.T., Rabe A., Iqbal K., Grundke-Iqbal I. Enhancement of dentate gyrus neurogenesis, dendritic and synaptic plasticity and memory by a neurotrophic peptide. Neurobiol. Aging 2011, 32(8):1420-1434.
7. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., Delocourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Solloway S., Stern Y., Visser P.J., Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007, 6(8):734-746.
8. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., Gage F.H. Neurogenesis in the adult human hippocampus. Nat. Med. 1998, 4(11):1313-1317.
9. Goedert M., Jakes R., Vanmechelen E. Monoclonal-antibody at8 recognizes tau-protein phosphorylated at both serine-202 and threonine-205. Neurosci. Lett. 1995, 189(3):167-170.
10. Greenamyre J.T., Maragos W.F. Neurotransmitter receptors in Alzheimer-disease. Cerebrovasc. Brain Metab. Rev. 1993, 5(2):61-94.
11. Greene S.J., Killiany R.J., Alzheimers Dis N. Hippocampal subregions are differentially affected in the progression to alzheimer's disease. Anat. Rec. Adv. Integr. Anat. Evol. Biol. 2012, 295(1):132-140.
12. Haris M., Nath K., Cai K., Singh A., Crescenzi R., Kogan F., Verma G., Reddy S., Hariharan H., Melhem E.R., Reddy R. Imaging of glutamate neurotransmitter alterations in Alzheimer's disease. NMR Biomed. 2013, 26(4):386-391.
13. Hurtado D.E., Molina-Porcel L., Iba M., Aboagye A.K., Paul S.M., Trojanowski J.Q., Lee V.M.Y. A beta accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Am. J. Pathol. 2010, 177(4):1977-1988.
14. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B.J., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393(6686):702-705.
15. Jin K.L., Galvan V., Xie L., Mao X.O., Gorostiza O.F., Bredesen D.E., Greenberg D.A. Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APP(sw, lnd))mice. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(36):13363-13367.
16. Jin K.L., Peel A.L., Mao X.O., Xie L., Cottrell B.A., Henshall D.C., Greenberg D.A. Increased hippocampal neurogenesis in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(1):343-347.
17. Johnson G.A., Ali-Sharief A., Badea A., Brandenburg J., Cofer G., Fubara B., Gewalt S., Hedlund L.W., Upchurch L. High-throughput morphologic phenotyping of the mouse brain with magnetic resonance histology. Neuroimage 2007, 37(1):82-89.
18. Lee V.M.Y., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 2001, 24:1121-1159.
19. Minkeviciene R., Ihalainen J., Malm T., Matilainen O., Keksa-Goldsteine V., Goldsteins G., Iivonen H., Leguit N., Glennon J., Koistinaho J., Banerjee P., Tanila H. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice. J. Neurochem. 2008, 105(3):584-594.
20. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease-FDG-PET studies in MCI and AD. Eur. J. Nucl. Med. Mol. Imaging 2005, 32(4):486-510.
21. Nilsen L.H., Rae C., Ittner L.M., Goetz J., Sonnewald U. Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation. J. Cereb. Blood Flow Metab. 2013, 33(5):684-691.
22. Rupsingh R., Borrie M., Smith M., Wells J.L., Bartha R. Reduced hippocampal glutamate in Alzheimer disease. Neurobiol. Aging 2011, 32(5):802-810.
23. Sancheti H., Kanamori K., Patil I., Brinton R.D., Ross B.D., Cadenas E. Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: a C-13 NMR study. J. Cereb. Blood Flow Metab. 2014, 34(2):288-296.
24. Sasaki K., Shimura H., Itaya M., Tanaka R., Mori H., Mizuno Y., Kosik K.S., Tanaka S., Hattori N. Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains. FEBS Lett. 2009, 583(13):2194-2200.
25. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298(5594):789-791.
26. Spampanato J., Sullivan R.K., Turpin F.R., Bartlett P.F., Sah P. Properties of doublecortin expressing neurons in the adult mouse dentate gyrus. PLoS One 2012, 7(9).
27. Terry R.D., Masliah E., Salmon D.P., Butters N., Deteresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease-synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30(4):572-580.
28. Yang D.W., Xie Z.Y., Stephenson D., Morton D., Hicks C.D., Brown T.M., Sriram R., O'Neill S., Raunig D., Bocan T. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible tau transgenic mice (rTg4510). Neuroimage 2011, 54(4):2652-2658.
29. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M.Y. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53(3):337-351.
30. Zhang B., Carroll J., Trojanowski J.Q., Yao Y.M., Iba M., Potuzak J.S., Hogan A.M.L., Xie S.X., Ballatore C., Smith A.B., Lee V.M.Y., Brunden K.R. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J. Neurosci. 2012, 32(11):3601-3611.